Skip to main content
FBLG
NASDAQ Life Sciences

FibroBiologics Doses First Patients in DFU Trial, Posts $4.1M Q2 Loss

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.7
Mkt Cap
$4.256M
52W Low
$0.62
52W High
$13.16
52W Position info
13% above low
Off High info
95% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

FBLG is trading near its 52-week low of $0.62 (13% above the low).

Summary

FibroBiologics initiated dosing in its Phase 1/2 trial of CYWC628 for diabetic foot ulcers, a key step for the clinical-stage biotech. Q2 financials show a $4.1M net loss with $1.7M in R&D and $2.4M in G&A expenses. The company ended June with $3.5M in cash, and the going concern warning and Nasdaq delisting notice from the recent 10-Q remain critical overhangs. Interim trial results are expected in the second half of 2026, with primary safety and efficacy data by year-end. This follows a series of dilutive financings, including a $9M private placement and a $3M public offering, as the company pushes toward multiple IND filings in Q4 2026.

At the time of this announcement, FBLG was trading at $0.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $0.62 to $13.16. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

FBLG - Latest Insights

FBLG
Oct 08, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.13
Real-time Price: $0.930 info
Change: -$0.200 (-18%) info
Market Cap: $6.192M info
FBLG
Sep 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $0.930 info
Change: -$0.500 (-35%) info
Market Cap: $6.192M info
FBLG
Sep 17, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $0.930 info
Change: -$0.555 (-37%) info
Market Cap: $6.192M info
FBLG
Sep 15, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $0.930 info
Change: -$0.6179 (-40%) info
Market Cap: $6.192M info
FBLG
Aug 11, 2026, 8:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.930 info
Change: -$0.020 (-2%) info
Market Cap: $6.192M info